ArticleSynthese2022
Statistical significance and its critics: practicing damaging science, or damaging scientific practice?
Article in Synthese, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- The Contribution of Bayesian Methods in Solving the Paradoxes of Classical Statistical Tests in Biomedical Research.Journal of clinical medicine · 2026Article
- A guide to interpreting systematic reviews and meta-analyses in neurosurgery and surgery.Acta neurochirurgica · 2024Review
- Integrating Artificial Intelligence and Machine Learning Into Cancer Clinical Trials.Seminars in radiation oncology · 2023Review
- The role of statistical significance in health risk assessment and in the decision-making process.Journal of preventive medicine and hygiene · 2023Article
- Significant Differences and Experimental Designs Do Not Necessarily Imply Clinical Relevance: Effect Sizes and Causality Claims in Antidepressant Treatments.Journal of clinical medicine · 2023Review
- Reporting and Interpreting Effect Sizes in Applied Health-Related Settings: The Case of Spirituality and Substance Abuse.Healthcare (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While the common procedure of statistical significance testing and its accompanying concept of p-values have long been surrounded by controversy, renewed concern has been triggered by the replication crisis in science. Many blame statistical significance tests themselves, and some regard them as sufficiently damaging to scientific practice as to warrant being abandoned. We take a contrary position, arguing that the central criticisms arise from misunderstanding and misusing the statistical tools, and that in fact the purported remedies themselves risk damaging science. We argue that banning the use of p-value thresholds in interpreting data does not diminish but rather exacerbates data-dredging and biasing selection effects. If an account cannot specify outcomes that will not be allowed to count as evidence for a claim-if all thresholds are abandoned-then there is no test of that claim. The contributions of this paper are: To explain the rival statistical philosophies underlying the ongoing controversy; To elucidate and reinterpret statistical significance tests, and explain how this reinterpretation ameliorates common misuses and misinterpretations; To argue why recent recommendations to replace, abandon, or retire statistical significance undermine a central function of statistics in science: to test whether observed patterns in the data are genuine or due to background variability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.